A team of researchers led by Harvard geneticist George Church at the Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) modified the genes of bacteria in a way that lets them programme exactly what chemical they want the cells to produce - and how much - through the bacteria's metabolic processes.
    
The concept of metabolic engineering, or manipulating bacteria to synthesise useful chemicals, is not new. However, the new findings demonstrate a technique that allows scientists to tap an almost endless list of chemicals they can produce using any type of bacteria, such as the common E coli, which was used in the study.

"This advance has implications for pharmaceutical, biofuel, and renewable chemical production," said Wyss Institute Founding Director Donald Ingber.

"By increasing the production output by such a huge factor, we would not only be improving current chemical production but could also make economical production of many new chemicals attainable," Ingber said. The team uses evolutionary mechanisms to trick the bacteria into self-eliminating the cells that are not high-output performers.
    
"We make the bacteria addicted to the chemicals we want them to produce," said Jameson Rogers, a lead co-author of the study, Graduate School of Arts and Sciences PhD candidate at Harvard School of Engineering and Applied Science, and Wyss Institute graduate researcher.
    
"Then, we treat them with an antibiotic that only allows the most productive cells to survive and make it on to the next round of evolution," Rogers said.
    
As each evolution cycle progresses, the bacteria become more and more effective at producing the desired chemical as they use the "survival of the fittest" principle to stamp out the weakest producer cells. The research was published in the Proceedings of the National Academy of Sciences (PNAS).

 

Latest News from Lifestyle News Desk